BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21168919)

  • 41. A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders.
    Gratacòs M; Soria V; Urretavizcaya M; González JR; Crespo JM; Bayés M; de Cid R; Menchón JM; Vallejo J; Estivill X
    Pharmacogenomics J; 2008 Apr; 8(2):101-12. PubMed ID: 17505499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression.
    Mendlewicz J; Crisafulli C; Calati R; Kocabas NA; Massat I; Linotte S; Kasper S; Fink M; Sidoti A; Scantamburlo G; Ansseau M; Antonijevic I; Forray C; Snyder L; Bollen J; Montgomery S; Zohar J; Souery D; Serretti A
    Neurosci Lett; 2012 May; 516(1):85-8. PubMed ID: 22487732
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DCNP1: a novel candidate gene for major depression.
    Willis-Owen SA; Shifman S; Copley RR; Flint J
    Mol Psychiatry; 2006 Feb; 11(2):121-2. PubMed ID: 16189510
    [No Abstract]   [Full Text] [Related]  

  • 44. Antidepressants and ABCB1 gene C3435T functional polymorphism: a naturalistic study.
    Menu P; Gressier F; Verstuyft C; Hardy P; Becquemont L; Corruble E
    Neuropsychobiology; 2010 Aug; 62(3):193-7. PubMed ID: 20664232
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients.
    Perlis RH; Fijal B; Dharia S; Heinloth AN; Houston JP
    Biol Psychiatry; 2010 Jun; 67(11):1110-3. PubMed ID: 20110084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.
    Kishi T; Kitajima T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Ozaki N; Iwata N
    Neuropsychobiology; 2009; 59(4):234-8. PubMed ID: 19571598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression.
    Domschke K; Dannlowski U; Ohrmann P; Lawford B; Bauer J; Kugel H; Heindel W; Young R; Morris P; Arolt V; Deckert J; Suslow T; Baune BT
    Eur Neuropsychopharmacol; 2008 Oct; 18(10):751-9. PubMed ID: 18579347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medical comorbidity affects antidepressant treatment response in patients with melancholic depression.
    Pohle K; Domschke K; Roehrs T; Arolt V; Baune BT
    Psychother Psychosom; 2009; 78(6):359-63. PubMed ID: 19738401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of prostaglandin-endoperoxide synthase 2 (PTGS2) polymorphisms and Alzheimer's disease in Chinese.
    Ma SL; Tang NL; Zhang YP; Ji LD; Tam CW; Lui VW; Chiu HF; Lam LC
    Neurobiol Aging; 2008 Jun; 29(6):856-60. PubMed ID: 17234302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacogenomics with antidepressants in the STAR*D study.
    Lin E; Chen PS
    Pharmacogenomics; 2008 Jul; 9(7):935-46. PubMed ID: 18597655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The angiotensin I converting enzyme insertion/deletion polymorphism influences therapeutic outcome in major depressed women, but not in men.
    Baghai TC; Schule C; Zill P; Deiml T; Eser D; Zwanzger P; Ella R; Rupprecht R; Bondy B
    Neurosci Lett; 2004 Jun; 363(1):38-42. PubMed ID: 15157992
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single nucleotide polymorphism analysis of corticotropin-releasing factor-binding protein gene in recurrent major depressive disorder.
    Van Den Eede F; Venken T; Del-Favero J; Norrback KF; Souery D; Nilsson LG; Van den Bossche B; Hulstijn W; Sabbe BG; Cosyns P; Mendlewicz J; Adolfsson R; Van Broeckhoven C; Claes SJ
    Psychiatry Res; 2007 Sep; 153(1):17-25. PubMed ID: 17599466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders.
    Kirchheiner J; Bertilsson L; Bruus H; Wolff A; Roots I; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S235-43. PubMed ID: 14677085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Possible association of CUX1 gene polymorphisms with antidepressant response in major depressive disorder.
    Sasayama D; Hiraishi A; Tatsumi M; Kamijima K; Ikeda M; Umene-Nakano W; Yoshimura R; Nakamura J; Iwata N; Kunugi H
    Pharmacogenomics J; 2013 Aug; 13(4):354-8. PubMed ID: 22584459
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of genetic polymorphisms in the glutamatergic and GABAergic systems and their interactions with environmental stressors on antidepressant response.
    Pu M; Zhang Z; Xu Z; Shi Y; Geng L; Yuan Y; Zhang X; Reynolds GP
    Pharmacogenomics; 2013 Feb; 14(3):277-88. PubMed ID: 23394390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The association of β-arrestin2 polymorphisms with response to antidepressant treatment in depressed patients.
    Petit AC; El Asmar K; David DJ; Gardier AM; Becquemont L; Fève B; Verstuyft C; Corruble E
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():74-79. PubMed ID: 29031912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Harm avoidance involved in mediating the association between nerve growth factor (NGF) gene polymorphisms and antidepressant efficacy in patients with major depressive disorder.
    Yeh YW; Kuo SC; Chen CY; Liang CS; Ho PS; Yen CH; Chen TY; Shyu JF; Wan FJ; Lu RB; Huang SY
    J Affect Disord; 2015 Sep; 183():187-94. PubMed ID: 26021968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin.
    Illi A; Viikki M; Poutanen O; Setälä-Soikkeli E; Nuolivirta T; Kampman O; Leinonen E; Huhtala H; Mononen N; Lehtimäki T
    Psychiatr Genet; 2013 Feb; 23(1):33-5. PubMed ID: 23250003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TPH-2 Polymorphisms Interact with Early Life Stress to Influence Response to Treatment with Antidepressant Drugs.
    Xu Z; Reynolds GP; Yuan Y; Shi Y; Pu M; Zhang Z
    Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27521242
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genome-wide association studies in pharmacogenomics of antidepressants.
    Lin E; Lane HY
    Pharmacogenomics; 2015; 16(5):555-66. PubMed ID: 25916525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.